About all

Diaper rash caused by yeast. Yeast Diaper Rash in Children: Causes, Symptoms, and Effective Treatment Strategies

by alexxlab

What are the main causes of yeast diaper rash in children. How can parents identify symptoms of yeast diaper rash. What are the most effective treatment strategies for yeast diaper rash in children. How can parents prevent yeast diaper rash from occurring or recurring. What are the potential complications of untreated yeast diaper rash. When should parents seek medical attention for their child’s diaper rash. What are the key differences between regular diaper rash and yeast diaper rash.

Understanding Yeast Diaper Rash: Causes and Risk Factors

Yeast diaper rash is a common condition that affects many infants and young children. It is caused by an overgrowth of Candida albicans, a type of fungus that naturally exists on the skin. Unlike regular diaper rash, which is primarily caused by irritation from prolonged exposure to wet diapers, yeast diaper rash has a distinct set of causes and risk factors.

The primary factors contributing to yeast diaper rash include:

  • Prolonged exposure to moisture
  • Warm, humid environment in the diaper area
  • Changes in skin pH due to urine and feces
  • Compromised skin barrier function
  • Use of antibiotics, which can disrupt the natural balance of bacteria and yeast on the skin
  • Underlying health conditions that weaken the immune system

Is there a specific age group more prone to yeast diaper rash? While yeast diaper rash can affect children of any age who wear diapers, it is most common in infants between 4 and 15 months old. This is likely due to the frequency of diaper changes and the developing immune system of young infants.

Identifying Symptoms: How to Recognize Yeast Diaper Rash

Recognizing the symptoms of yeast diaper rash is crucial for proper treatment and prevention of complications. While some symptoms may overlap with regular diaper rash, there are distinct characteristics that set yeast diaper rash apart.

Key symptoms of yeast diaper rash include:

  1. Bright red, slightly raised rash with defined edges
  2. Small red spots or pimples around the main rash (satellite lesions)
  3. Persistent rash that does not improve with standard diaper rash treatments
  4. Rash that extends into skin folds
  5. Scaly or flaky appearance of the affected skin
  6. Possible burning or itching sensation (indicated by increased fussiness during diaper changes)

Can yeast diaper rash spread to other parts of the body? Yes, in some cases, yeast diaper rash can spread beyond the diaper area. It may affect skin folds in the neck, armpits, or other areas prone to moisture and warmth. If you notice similar rashes on other parts of your child’s body, consult a healthcare provider for proper diagnosis and treatment.

Effective Treatment Strategies for Yeast Diaper Rash

Treating yeast diaper rash requires a different approach compared to regular diaper rash. The goal is to eliminate the overgrowth of yeast and restore the skin’s natural balance. Here are some effective treatment strategies:

1. Antifungal Medications

The primary treatment for yeast diaper rash is the use of antifungal creams or ointments. These may include:

  • Over-the-counter options like miconazole or clotrimazole
  • Prescription-strength antifungals such as nystatin or ketoconazole

Apply the antifungal medication as directed by your healthcare provider, typically 2-3 times daily for 7-14 days.

2. Proper Diaper Hygiene

Maintaining good diaper hygiene is crucial for treating and preventing yeast diaper rash:

  • Change diapers frequently, especially after bowel movements
  • Clean the diaper area gently with warm water and pat dry
  • Allow the skin to air dry for 5-10 minutes before applying a new diaper
  • Avoid using baby wipes containing alcohol or fragrances

3. Barrier Creams and Ointments

After applying antifungal medication, use a barrier cream or ointment to protect the skin:

  • Zinc oxide-based creams
  • Petroleum jelly
  • Dimethicone-based products

These create a protective layer between the skin and potential irritants.

4. Dietary Considerations

For breastfed infants, some healthcare providers may recommend dietary changes for the mother, such as reducing sugar and yeast intake. However, the effectiveness of this approach is not well-established and should be discussed with a healthcare professional.

How long does it typically take for yeast diaper rash to clear up with proper treatment? With appropriate antifungal treatment and good diaper hygiene, most cases of yeast diaper rash begin to improve within 2-3 days. Complete resolution usually occurs within 1-2 weeks. If the rash persists beyond this time, consult your healthcare provider for further evaluation.

Preventing Yeast Diaper Rash: Proactive Measures for Parents

Prevention is key when it comes to yeast diaper rash. By implementing the following strategies, parents can significantly reduce the risk of their child developing this uncomfortable condition:

  1. Change diapers frequently, ideally every 2-3 hours or immediately after bowel movements
  2. Clean the diaper area thoroughly but gently during each change
  3. Allow the skin to air dry completely before putting on a new diaper
  4. Use breathable, absorbent diapers to reduce moisture
  5. Consider using cloth diapers, which may reduce the risk of yeast overgrowth
  6. Avoid tight-fitting diapers or plastic pants over diapers
  7. Use mild, fragrance-free soaps and avoid products containing alcohol
  8. If using baby powder, opt for cornstarch-based options rather than talcum powder
  9. For bottle-fed babies, clean and sterilize bottles regularly to prevent yeast growth
  10. Wash hands thoroughly before and after diaper changes to prevent spread of yeast

Are there any specific dietary recommendations for preventing yeast diaper rash? While there’s limited scientific evidence supporting dietary changes for prevention, some healthcare providers suggest reducing sugar intake in the child’s diet (for older infants and toddlers) or the breastfeeding mother’s diet. Always consult with a pediatrician before making significant dietary changes.

Potential Complications of Untreated Yeast Diaper Rash

While yeast diaper rash is generally not serious, if left untreated, it can lead to potential complications:

  • Bacterial infection: The compromised skin barrier can allow bacteria to enter, leading to a secondary bacterial infection.
  • Spread of infection: Yeast can spread to other areas of the body, particularly in skin folds.
  • Discomfort and irritability: Persistent rash can cause significant discomfort for the child, leading to sleep disturbances and irritability.
  • Skin damage: Prolonged inflammation can potentially lead to scarring or changes in skin pigmentation.
  • Resistance to treatment: If not treated properly, the yeast may become resistant to common antifungal medications, making future treatment more challenging.

Can untreated yeast diaper rash lead to systemic yeast infections? In rare cases, particularly in children with weakened immune systems, untreated yeast diaper rash could potentially lead to systemic yeast infections. However, this is extremely uncommon in otherwise healthy children. Nonetheless, it underscores the importance of proper treatment and medical attention when necessary.

When to Seek Medical Attention for Diaper Rash

While many cases of diaper rash, including yeast diaper rash, can be managed at home, there are situations where medical attention is necessary. Parents should consult a healthcare provider if:

  • The rash persists for more than 3-4 days despite home treatment
  • The rash appears to be severe, with blisters, open sores, or bleeding
  • The child develops a fever (temperature above 100.4°F or 38°C)
  • The rash spreads beyond the diaper area
  • The child shows signs of discomfort, such as excessive crying or difficulty sleeping
  • There are signs of secondary bacterial infection, such as increased redness, swelling, or pus
  • The child has recently been on antibiotics
  • The rash is accompanied by thrush (white patches in the mouth)

What should parents expect during a medical consultation for yeast diaper rash? During the consultation, the healthcare provider will examine the rash and may take a skin sample for laboratory analysis if the diagnosis is uncertain. They may prescribe stronger antifungal medications or additional treatments if necessary. The provider will also offer guidance on proper care and prevention strategies.

Differentiating Yeast Diaper Rash from Other Skin Conditions

Distinguishing yeast diaper rash from other skin conditions is crucial for appropriate treatment. Here are some key differences:

Yeast Diaper Rash vs. Regular Diaper Rash:

  • Appearance: Yeast rash is usually bright red with defined edges and satellite lesions, while regular diaper rash is often more diffuse and pink or red.
  • Location: Yeast rash often affects skin folds, whereas regular diaper rash typically spares these areas.
  • Duration: Yeast rash tends to persist longer and doesn’t respond to standard diaper rash treatments.

Yeast Diaper Rash vs. Bacterial Infection:

  • Color: Yeast rash is bright red, while bacterial infections may have a deeper red or purplish hue.
  • Texture: Yeast rash may be scaly or flaky, whereas bacterial infections can cause oozing or crusting.
  • Systemic symptoms: Bacterial infections are more likely to cause fever or general illness.

Yeast Diaper Rash vs. Seborrheic Dermatitis:

  • Distribution: Seborrheic dermatitis often affects the scalp, face, and other areas in addition to the diaper area.
  • Appearance: Seborrheic dermatitis typically has a greasy, yellow scale, unlike the red, raised appearance of yeast rash.

Can a child have multiple types of diaper rash simultaneously? Yes, it’s possible for a child to have both yeast diaper rash and another type of skin condition concurrently. This is one reason why accurate diagnosis by a healthcare provider is important, especially for persistent or severe cases.

In conclusion, understanding the causes, symptoms, and treatment strategies for yeast diaper rash is essential for parents and caregivers. By recognizing the signs early, implementing proper treatment, and following preventive measures, the discomfort associated with yeast diaper rash can be minimized, and complications can be avoided. Always consult with a healthcare provider if you have concerns about your child’s diaper rash or if it doesn’t improve with home treatment.

Yeast Diaper Rash in Children: Care Instructions

Skip Navigation

Your Care Instructions

Any rash on the area covered by a diaper is called diaper rash. Many diaper rashes are caused when a child wears a wet diaper for too long. But diaper rashes can also be caused by candida albicans, a type of yeast. Your child may also have the two types of rashes at the same time.

A yeast diaper rash is not serious, but it may need to be treated with an antifungal cream.

Follow-up care is a key part of your child’s treatment and safety. Be sure to make and go to all appointments, and call your doctor if your child is having problems. It’s also a good idea to know your child’s test results and keep a list of the medicines your child takes.

How can you care for your child at home?

  • Your doctor may prescribe a medicated cream, powder, or ointment, or recommend that you buy an over-the-counter one at a grocery store or drugstore. Use it as directed.
  • Change diapers as soon as they are wet or dirty. Before you put a new diaper on your baby, gently wash the diaper area with warm water. Rinse and pat dry. Wash your hands before and after each diaper change.
  • Air the diaper area for 5 to 10 minutes before you put on a new diaper.
  • Do not use baby wipes that contain alcohol or propylene glycol while your baby has a rash. These may burn the skin.
  • Do not use baby powder while your baby has a rash. The powder can build up in the skin folds and hold moisture.

When should you call for help?

Call your doctor now or seek immediate medical care if:

  • Your baby has blisters, open sores, or scabs in the diaper area.
  • Your baby has signs of a more serious infection, including:
    • Increased pain, swelling, warmth, or redness.
    • Red streaks leading from the rash.
    • Pus draining from the rash.
    • A fever.

Watch closely for changes in your child’s health, and be sure to contact your doctor if:

  • Your baby’s diaper rash looks like a rash that is on other parts of your baby’s body.
  • Your baby’s rash is not better after 2 days of treatment.

Where can you learn more?

Go to https://www.healthwise.net/patientEd

Enter S981 in the search box to learn more about “Yeast Diaper Rash in Children: Care Instructions”.

Superficial Mycoses Associated with Diaper Dermatitis

1. Wolf R, Wolf D, Tüzün B, Tüzün Y. Diaper dermatitis. Clin Dermatol. 2000;18:657–660. doi: 10.1016/S0738-081X(00)00157-7. [PubMed] [CrossRef] [Google Scholar]

2. Ward DB, Fleischer AB, Jr, Feldman SR, Krowchuk DP. Characterization of diaper dermatitis in the United States. Arch Pediatr Adolesc Med. 2000;154:943–946. doi: 10.1001/archpedi.154.9.943. [PubMed] [CrossRef] [Google Scholar]

3. Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol. 2014;32:477–487. doi: 10.1016/j.clindermatol.2014.02.003. [PubMed] [CrossRef] [Google Scholar]

4. Parry EL, Foshee WS, Marks JG. Diaper dermatophytosis. Am J Dis Child. 1982;136:273–274. [PubMed] [Google Scholar]

5. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18:13–26. doi: 10.1111/j.1468-3083.2004.00693.x. [PubMed] [CrossRef] [Google Scholar]

6. Martins N, Ferreira IC, Barros L, Silva S, Henriques M. Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia. 2014;177:223–240. doi: 10.1007/s11046-014-9749-1. [PubMed] [CrossRef] [Google Scholar]

7. Kazaks EL, Lane AT. Diaper dermatitis. Pediatr Dermatol. 2000;47:909–919. [PubMed] [Google Scholar]

8. Tüzün Y, Wolf R, Bağlam S, Engin B. Diaper (napkin) dermatitis: a fold (intertriginous) dermatosis. Clin Dermatol. 2015;33:477–482. doi: 10.1016/j.clindermatol.2015.04.012. [PubMed] [CrossRef] [Google Scholar]

9. Adalat S, Wall D, Goodyear H. Diaper dermatitis-frequency and contributory factors in hospital attending children. Pediatr Dermatol. 2007;24:483–488. doi: 10.1111/j.1525-1470.2007.00499.x. [PubMed] [CrossRef] [Google Scholar]

10. Philipp R, Hughes A, Golding J. Getting to the bottom of nappy rash. ALSPAC survey team. Avon longitudinal study of pregnancy and childhood. Br J Gen Pract. 1997;47:493–497. [PMC free article] [PubMed] [Google Scholar]

11. Stamatas GN, Tierney NK. Diaper dermatitis: etiology, manifestations, prevention, and management. Pediatr Dermatol. 2014;31:1–7. doi: 10.1111/pde.12245. [PubMed] [CrossRef] [Google Scholar]

12. Berg RW, Milligan MC, Sarbaugh FC. Association of skin wetness and pH with diaper dermatitis. Pediatr Dermatol. 1994;11:18–20. doi: 10.1111/j.1525-1470.1994.tb00066.x. [PubMed] [CrossRef] [Google Scholar]

13. Frage M, Tzeghai G, Miller K, et al. Dermatological effects and management of urine and feces on infants and incontinent adults. Br J Med Med Res. 2014;4:3671–3688. doi: 10.9734/BJMMR/2014/10006. [CrossRef] [Google Scholar]

14. Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Invest Dermatol. 2008;128:1728–1736. doi: 10.1038/sj.jid.5701239. [PubMed] [CrossRef] [Google Scholar]

15. Stamatas GN, Zerweck C, Grove G, Martin KM. Documentation of impaired epidermal barrier in mild and moderate diaper dermatitis in vivo using noninvasive methods. Pediatr Dermatol. 2011;28:99–107. doi: 10.1111/j.1525-1470.2011.01308.x. [PubMed] [CrossRef] [Google Scholar]

16. Odio M, Friedlander SF. Diaper dermatitis and advances in diaper technology. Curr Opin Pediatr. 2000;12:342–346. doi: 10.1097/00008480-200008000-00011. [PubMed] [CrossRef] [Google Scholar]

17. Brook I. Microbiology of secondarily infected diaper dermatitis. Int J Dermatol. 1992;31:700–702. doi: 10.1111/j.1365-4362.1992.tb01375.x. [PubMed] [CrossRef] [Google Scholar]

18. Ferrazzini G, Kaiser RR, Hirsig-Cheng SK, Wehrli M, Della Casa V, Pohlig G, Gonser S, Graf F, Jörg W. Microbiological aspects of diaper dermatitis. Dermatology. 2003;206:136–141. doi: 10.1159/000068472. [PubMed] [CrossRef] [Google Scholar]

19. Gupta AK, Skinner AR. Management of diaper dermatitis. Int J Dermatol. 2004;43:830–834. doi: 10.1111/j.1365-4632.2004.02405.x. [PubMed] [CrossRef] [Google Scholar]

20. Adam R. Skin care of the diaper area. Pediatr Dermatol. 2008;25:427–433. doi: 10.1111/j.1525-1470.2008.00725.x. [PubMed] [CrossRef] [Google Scholar]

21. Campbell RL, Bartlett AV, Sarbaugh FC, Pickering LK. Effects of diaper types on diaper dermatitis associated with diarrhea and antibiotic use in children in day-care centers. Pediatr Dermatol. 1988;5:83–87. doi: 10.1111/j.1525-1470.1988.tb01143.x. [PubMed] [CrossRef] [Google Scholar]

22. Hoppe JE. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J. 1997;16:885–894. doi: 10.1097/00006454-199709000-00013. [PubMed] [CrossRef] [Google Scholar]

23. De Bernardis F, Mühlschlegel FA, Cassone A, Fonzi WA. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun. 1998;66:3317–3325. [PMC free article] [PubMed] [Google Scholar]

24. Allen AM, King RD. Occlusion, carbon dioxide, and fungal skin infections. Lancet. 1978;18(1):360–362. doi: 10.1016/S0140-6736(78)91084-X. [PubMed] [CrossRef] [Google Scholar]

25. Akin F, Spraker M, Aly R, Leyden J, Raynor W, Landin W. Effects of breathable disposable diapers: reduced prevalence of Candida and common diaper dermatitis. Pediatr Dermatol. 2001;18:282–290. doi: 10.1046/j.1525-1470.2001.01929.x. [PubMed] [CrossRef] [Google Scholar]

26. Makrides HC, MacFarlane TW. An investigation of the factors involved in increased adherence of C. albicans to epithelial cells mediated by E. coli. Microbios. 1983;38:177–185. [PubMed] [Google Scholar]

27. Dan M, Segal R, Marder V, Leibovitz A. Candida colonization of the vagina in elderly residents of a long-term-care hospital. Eur J Clin Microbiol Infect Dis. 2006;25:394–396. doi: 10.1007/s10096-006-0150-y. [PubMed] [CrossRef] [Google Scholar]

28. Foureur N, Vanzo B, Meaume S, Senet P. Prospective aetiological study of diaper dermatitis in the elderly. Br J Dermatol. 2006;155:941–946. doi: 10.1111/j.1365-2133.2006.07423.x. [PubMed] [CrossRef] [Google Scholar]

29. Beguin AM, Malaquin-Pavan E, Guihaire C, Hallet-Lezy AM, Souchon S, Homann V, Zöllner P, et al. Improving diaper design to address incontinence associated dermatitis. BMC Geriatr. 2010;22:86. doi: 10.1186/1471-2318-10-86. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

30. Coughlin CC, Eichenfield LF, Frieden IJ. Diaper dermatitis: clinical characteristics and differential diagnosis. Pediatr Dermatol. 2014;31(Suppl 1):19–24. doi: 10.1111/pde.12500. [PubMed] [CrossRef] [Google Scholar]

31. Shin HT. Diagnosis and management of diaper dermatitis. Pediatr Clin North Am. 2014;61:367–382. doi: 10.1016/j.pcl.2013.11.009. [PubMed] [CrossRef] [Google Scholar]

32. Ozdemir A, Bas VN. Iatrogenic Cushing’s syndrome due to overuse of topical steroid in the diaper area. J Trop Pediatr. 2014;60:404–406. doi: 10.1093/tropej/fmu036. [PubMed] [CrossRef] [Google Scholar]

33. Blanco D, van Rossem K. A prospective two-year assessment of miconazole miconazole resistance in Candida spp. With repeated treatment with 0.25% miconazole nitrate ointment in neonates and infants with moderate to severe diaper dermatitis complicated by cutaneous candidiasis. Pediatr Dermatol. 2013;30:717–724. doi: 10.1111/pde.12107. [PubMed] [CrossRef] [Google Scholar]

34. Mohamadi J, Motaghi M, Panahi J, Havasian MR, Delpisheh A, Azizian M, Pakzad I. Anti-fungal resistance in Candida isolated from oral and diaper rash candidiasis in neonates. Bioinformation. 2014;10:667–670. doi: 10.6026/97320630010667. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

35. Gallup E, Plott T, Ciclopirox TS Investigators A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans. J Drugs Dermatol. 2005;4:29–34. [PubMed] [Google Scholar]

36. Sharma A, Saple DG, Surjushe A, et al. Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. Mycoses. 2011;54:217–222. doi: 10.1111/j.1439-0507.2009.01801.x. [PubMed] [CrossRef] [Google Scholar]

37. Bonifaz A, Tirado-Sánchez A, Graniel MJ, Mena C, Valencia A, Ponce-Olivera RM. The efficacy and safety of sertaconazole cream (2%) in diaper dermatitis candidiasis. Mycopathologia. 2013;175:249–254. doi: 10.1007/s11046-013-9642-3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

38. Kahana M, Levi A, Cohen M, Schewach-Millet M, Shalish L. Dermatophytosis of the diaper area. Clin Pediatr (Phila) 1987;26:149–151. doi: 10.1177/000992288702600310. [PubMed] [CrossRef] [Google Scholar]

39. Cavanaugh RM, Jr, Greeson JD. Trichophyton rubrum. Infection of the diaper area. Arch Dermatol. 1982;118:446. doi: 10.1001/archderm.1982.01650180080026. [PubMed] [CrossRef] [Google Scholar]

40. Congly H. Infection of the diaper area caused by Epidermophyton floccosum. Can Med Assoc J. 1983;129:410–411. [PMC free article] [PubMed] [Google Scholar]

41. Baudraz-Rosselet F, Ruffieux P, Mancarella A, Monod M, Frenk E. Diaper dermatitis due to Trichophyton verrucosum. Pediatr Dermatol. 1993;10:368–369. doi: 10.1111/j.1525-1470.1993. tb00402.x. [PubMed] [CrossRef] [Google Scholar]

42. Peral ME, Arenas R. Dermatofitosis en la zona del pañal. Presentación de cinco casos. Dermatología Rev Mex. 2001;45:4–7. [Google Scholar]

43. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008;166:353–367. doi: 10.1007/s11046-008-9109-0. [PubMed] [CrossRef] [Google Scholar]

44. Popescu V. Common dermatitis in infants (dermatitis seborrheica, atopic dermatitis and “diaper dermatitis” Pediatrie (Bucur) 1992;41:28–34. [PubMed] [Google Scholar]

45. Kekki OM, Scheynius A, Poikonen S, Koskinen A, Kautiainen H, Turjanmaa K. Sensitization to Malassezia in children with atopic dermatitis combined with food allergy. Pediatr Allergy Immunol. 2013;24:244–246. doi: 10.1111/pai.12057. [PubMed] [CrossRef] [Google Scholar]

46. Takahata Y, Sugita T, Kato H, Nishikawa A, Hiruma M, Muto M. Cutaneous Malassezia flora in atopic dermatitis differs between adults and children. Br J Dermatol. 2007;157:1178–1182. doi: 10.1111/j.1365-2133.2007.08193.x. [PubMed] [CrossRef] [Google Scholar]

47. Tucker AT, Emerson AN, Wyatt JP, Brodell RT. Case report: diaper dermatitis presenting as pustules. J Drugs Dermatol. 2014;13:1153–1154. [PubMed] [Google Scholar]

48. Scheinfeld N. Diaper dermatitis: a review and brief survey of eruptions of the diaper area. Am J Clin Dermatol. 2005;6:273–281. doi: 10.2165/00128071-200506050-00001. [PubMed] [CrossRef] [Google Scholar]

49. Blaise G, Nikkels AF, Hermanns-Lê T, Nikkels-Tassoudji N, Piérard GE. Corynebacterium-associated skin infections. Int J Dermatol. 2008;47:884–890. doi: 10.1111/j.1365-4632.2008.03773.x. [PubMed] [CrossRef] [Google Scholar]

50. O’Dell ML. Skin and wound infections: an overview. Am Fam Physician. 1998;57:2424–2432. [PubMed] [Google Scholar]

51. Holdiness MR. Management of cutaneous erythrasma. Drugs. 2002;62:1131–1141. doi: 10.2165/00003495-200262080-00002. [PubMed] [CrossRef] [Google Scholar]

52. Henry F, Piérard-Franchimont C, Flagothier C, Piérard GE. How I treat…a stoutness-associated intertrigo. Rev Med Liege. 2007;62:67–70. [PubMed] [Google Scholar]

Clotrimazole ointment – instructions for use, for women, analogues, what helps?

Clotrimazole is a broad spectrum antimycotic or antifungal agent. The antimycotic properties of clotrimazole were discovered in the late 1960s. The drug belongs to the category of imidazole azole antifungals. It is available in a variety of dosage forms, including creams, ointments, tablets, and slow-dissolving capsules.

Contents

  1. Application of the preparation

  2. Pharmacological action

  3. Absorption

  4. Overdose

  5. Features

  6. Application and dosage of

  7. Analogs

Clotrimazole may be used to treat anemia

In addition to its antifungal activity, clotrimazole has become a drug of interest in the treatment of a number of other diseases such as sickle cell anemia, malaria and some types of cancer. This drug’s minimal side effects and uncomplicated metabolic profile have led to its widespread use for the treatment of fungal outbreaks such as vaginal infections caused by yeast spores (vulvitis candidiasis or thrush) and fungal infections of the feet.

Use of

Clotrimazole Cream is indicated for the topical treatment of the following skin infections:

  • Tinea pedis, tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Floccosum Epidermophyton;
  • Candidiasis due to Candida albicans;
  • Herpes zoster due to Malassezia furfur;
  • Diaper rash infected with Candida Albicans;

In some preparations, clotrimazole may be combined with betamethasone dipropionate, corticosteroids.

Oral formulation is indicated as a prophylactic agent to reduce the incidence of oral and pharyngeal candidiasis in immunocompromised patients undergoing chemotherapy, radiation therapy, or steroid therapy used in the treatment of leukemia, cancer, or kidney transplantation. The drug is not indicated for the treatment of any systemic mycoses.

Pharmacological action

Clotrimazole is a broad spectrum antifungal agent that inhibits the growth of pathogenic yeasts by altering the permeability of cell membranes. The action of clotrimazole is fungistatic at drug concentrations up to 20 μg / ml and may be fungicidal in vitro against Candida albicans and other species of the Candida genus at higher concentrations. Unfortunately, resistance to clotrimazole, which was rare in the past, is now common among various patient groups.

The drug Clotrimazole fights fungus well

Clotrimazole is generally considered to be fungistatic rather than fungicidal, although this difference is not absolute because clotrimazole exhibits fungicidal properties at higher concentrations.

The action of the drug is based primarily on damage to the permeability barrier in the fungal cell membrane. Clotrimazole causes inhibition of the biosynthesis of ergosterol, an essential component of fungal cell membranes. If ergosterol synthesis is either completely or partially inhibited, the cell is no longer able to create an intact and functional cell membrane. Since ergosterol directly stimulates the growth of fungal cells in a hormone-like manner, the rapid onset of the above processes results in dose-dependent inhibition of fungal growth.

Although there is a decrease in ergosterol, due to the inhibition of lanosterol-14-demethylase (also known as CYP51), which is considered responsible for the antimycotic properties of clotrimazole, this drug also shows other pharmacological effects. These include inhibition of the Ca2+-ATPase of the sarcoplasmic reticulum, depletion of intracellular calcium, and blocking of calcium-dependent potassium channels and voltage-dependent calcium channels. The action of clotrimazole on these complexes explains other effects of this drug, which differ from its antifungal activity.

Absorption

Because clotrimazole is generally not absorbed to a significant extent, drug interactions are not a major problem with its use.

Topical form is minimally absorbed in serum and tissues.

Overdose

Overdose symptoms include erythema, tingling, blistering, peeling, swelling, itching, urticaria, burning and general skin irritation, and convulsions. As with all topical preparations, skin sensitization may occur.

Clotrimazole does not pose a risk of acute toxicity as it is unlikely to occur after a single vaginal or dermal application. Overdose when applied is possible over a large area under conditions favorable for absorption, or by accidental oral ingestion. There is no specific antidote.

Features

Clotrimazole should not be used during the first trimester of pregnancy unless the physician considers its use necessary for the health of the patient. The drug should not be used during critical days in the treatment of candidal vulvitis (thrush). In the case of breastfeeding, clotrimazole can only be used as directed by the attending physician.

The drug weakens the effect of nystatin, natamycin, amphotericin B with simultaneous use. The cream is not used to treat nails or fungal diseases of the head.

When applied topically, Clotrimazole cream is rubbed into the affected areas of the skin. Do not apply the product to the area around the eyes.

Clotrimazole is not prescribed for infants and premature babies

For the treatment of candidal vulvitis, the capsule is inserted into the vulva, and the perineum and mucous tissues are treated with a cream. During the treatment of candidal vulvitis, unprotected sexual intercourse should be avoided so as not to infect the partner. If infection nevertheless took place, the treatment should also be carried out by the partner. During therapy with the drug, tampons, spermicides and other vaginal agents should not be used.

Application and dosage of

Clotrimazole cream is available in tubes of 20 grams. The 1st gram of the drug contains 20 mg of the active ingredient.

The drug is rubbed into the affected areas of the skin with a thin layer 2-3 times a day.

The duration of the course of therapy is:

  • dermatomycosis – 3-4 weeks;
  • erythrasma – 2-4 weeks;
  • multicolored lichen – 1-3 weeks;
  • candidal vulvitis and candidal balanitis – 1-2 weeks.

To consolidate the positive result of treatment and prevent the recurrence of the disease, the course can be continued for 2 weeks after the disappearance of the symptoms of the disease.

If the patient’s condition does not improve after 4 weeks of use of the drug, you should consult a doctor.

In case of hypersensitivity to the drug, allergic reactions, headache, other manifestations of side effects, you should consult a doctor. When prescribing a course of treatment, the patient must necessarily report a history of sexually transmitted diseases, allergic reactions, if the patient’s temperature is above 38C.

Analogs

Analogues

Clotrimazole is also known by trade names such as Amiklon, Imidil, Candibene, Candide, Candizol, Kanesten, Canizon, Funginal, Fungicip.

When deciding on the choice of ointment or cream, one should first of all proceed from the amount of active substance per unit volume of the dosage form.

Sources

  • Mitronin AV, Tsarev VN Clinical and microbiological evaluation of the effectiveness of endocanal application of the bioactive gel “collapan” in the treatment of chronic periodontitis // New in dentistry. – M., 2004. – No. 5. – S. 50-60;
  • Borovsky E. V. Therapeutic dentistry / E. V. Borovsky (and others). – M.: Medicine, 2003. – 797 p.

Cloritmazol

Clotrimazole 1% Topical Cream 20 g 1

GlaxoSmithKline, Poland

Price

from 200₽

Clotrimazole-Acriquine, 1%, topical ointment, 20 g, 1 pc.

Akrikhin, Russia

Price

from 119₽

There are contraindications. Specialist consultation is required.

The information is presented for informational purposes only and is not medical advice or a guide to treatment by uteka.ru.

GBOUDPORO “TsPK” – Rostov-on-Don – Main

Distance learning

Vocational retraining

9June 12 — Day of Russia

June 5 – World Environment Day

May 12 – International nurse’s day 2023

May 9 – Victory Day 2023

May 1 – Spring and Labor Day 2023

April 7 – World Health Day

×

Error

RuntimeException: Error decoding JSON data: Control character error, possibly incorrectly encoded in /var/www/cpk/data/www/cpkmed.ru/libraries/vendor/joomla/registry/src/Format/ json.php:78
Stack trace:
#0 /var/www/cpk/data/www/cpkmed.ru/libraries/vendor/joomla/registry/src/Registry.php(370): Joomla\Registry\Format\Json->stringToObject(‘{“show_title” :0…’, Array)
#1 /var/www/cpk/data/www/cpkmed. ru/libraries/vendor/joomla/registry/src/Registry.php(76): Joomla\Registry\Registry->loadString(‘{“show_title”:0 …’)
#2 /var/www/cpk/data/www/cpkmed.ru/components/com_content/models/article.php(165): Joomla\Registry\Registry->__construct(‘{“show_title”:0…’ )
#3 /var/www/cpk/data/www/cpkmed.ru/libraries/src/MVC/View/HtmlView.php(425): ContentModelArticle->getItem()
#4 /var/www/cpk/data/www/cpkmed.ru/components/com_content/views/article/view.html.php(42): Joomla\CMS\MVC\View\HtmlView->get(‘Item’ )
#5 /var/www/cpk/data/www/cpkmed.ru/libraries/src/MVC/Controller/BaseController.php(672): ContentViewArticle->display()
#6 /var/www/cpk/data/www/cpkmed.ru/components/com_content/controller.php(118): Joomla\CMS\MVC\Controller\BaseController->display(true, Array)
#7 /var/www/cpk/data/www/cpkmed.ru/libraries/src/MVC/Controller/BaseController.php(710): ContentController->display()
#8 /var/www/cpk/data/www/cpkmed.ru/components/com_content/content.php(43): Joomla\CMS\MVC\Controller\BaseController->execute(”)
#9/var/www/cpk/data/www/cpkmed.